Cargando…
Development of a Population Pharmacokinetic Model of Vancomycin and its Application in Chinese Geriatric Patients with Pulmonary Infections
BACKGROUND: The optimal use of vancomycin in the elderly requires information about the drug’s pharmacokinetics and the influence of various factors on the drug’s disposition. However, because of sampling restrictions, it is often difficult to perform traditional pharmacokinetic studies in elderly p...
Autores principales: | Zhou, Ying, Gao, Feifei, Chen, Chaoyang, Ma, Lingyun, Yang, Ting, Liu, Xiao, Liu, Yaou, Wang, Xiaoqing, Zhao, Xia, Que, Chengli, Li, Shuangling, Lv, JiCheng, Cui, Yimin, Yang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520475/ https://www.ncbi.nlm.nih.gov/pubmed/30506225 http://dx.doi.org/10.1007/s13318-018-0534-2 |
Ejemplares similares
-
Population pharmacokinetic modeling and clinical application of vancomycin in Chinese patients hospitalized in intensive care units
por: Lin, Zhong, et al.
Publicado: (2021) -
Population Pharmacokinetics of Vancomycin in Chinese ICU Neonates: Initial Dosage Recommendations
por: Li, Zhi-ling, et al.
Publicado: (2018) -
A population pharmacokinetic model for individualised dosage regimens of vancomycin in Chinese neonates and young infants
por: Song, Lin, et al.
Publicado: (2017) -
Influence of the OATP Polymorphism on the Population Pharmacokinetics of Methotrexate in Chinese Patients
por: Wang, Zhiqi, et al.
Publicado: (2019) -
Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials
por: Chaoyang, Chen, et al.
Publicado: (2022)